GE HealthCare's Continued Underperformance in Patient Care Solutions Business 'Disappointing,' Oppenheimer Says

MT Newswires Live

Jul 31

GE HealthCare Technologies' (GEHC) continued underperformance in the Patient Care Solutions business is "disappointing," with the segment experiencing fulfillment challenges in Q2, Oppenheimer said in a Thursday note.

The company is exploring a strategic review for PCS, which includes either continued ownership, sale, or other value enhancing transactions, Oppenheimer said, adding that the timeline of the review remains unclear, with GE HealthCare looking to stabilize the business first.

Additionally, the company reiterated organic revenue growth at 3% to 4%, as well as adjusted earnings per share $4.80 to $5.00, compared with Oppenheimer estimate of $4.90, according to the note.

Oppenheimer said it remains constructive long-term given the company's ecosystem and multiple growth levers, although China, tariffs, and other macro pressures remain as overhangs.

Oppenheimer maintained its outperform rating with a price target of $85 on GE HealthCare.

Price: 69.04, Change: -2.86, Percent Change: -3.98

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2655807289"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2655807289\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2655807289?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 01:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655807289","market":"fut","top_or_hot":-1,"title":"GE HealthCare's Continued Underperformance in Patient Care Solutions Business 'Disappointing,' Oppenheimer Says","media":"MT Newswires Live","content":"<html><body><p> GE HealthCare Technologies' (GEHC) continued underperformance in the Patient Care Solutions business is \"disappointing,\" with the segment experiencing fulfillment challenges in Q2, Oppenheimer said in a Thursday note.</p><p>The company is exploring a strategic review for PCS, which includes either continued ownership, sale, or other value enhancing transactions, Oppenheimer said, adding that the timeline of the review remains unclear, with GE HealthCare looking to stabilize the business first.</p><p>Additionally, the company reiterated organic revenue growth at 3% to 4%, as well as adjusted earnings per share $4.80 to $5.00, compared with Oppenheimer estimate of $4.90, according to the note.</p><p>Oppenheimer said it remains constructive long-term given the company's ecosystem and multiple growth levers, although China, tariffs, and other macro pressures remain as overhangs.</p><p>Oppenheimer maintained its outperform rating with a price target of $85 on GE HealthCare.</p><p>Price: 69.04, Change: -2.86, Percent Change: -3.98</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GE HealthCare's Continued Underperformance in Patient Care Solutions Business 'Disappointing,' Oppenheimer Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGE HealthCare's Continued Underperformance in Patient Care Solutions Business 'Disappointing,' Oppenheimer Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-31 01:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> GE HealthCare Technologies' (GEHC) continued underperformance in the Patient Care Solutions business is \"disappointing,\" with the segment experiencing fulfillment challenges in Q2, Oppenheimer said in a Thursday note.</p><p>The company is exploring a strategic review for PCS, which includes either continued ownership, sale, or other value enhancing transactions, Oppenheimer said, adding that the timeline of the review remains unclear, with GE HealthCare looking to stabilize the business first.</p><p>Additionally, the company reiterated organic revenue growth at 3% to 4%, as well as adjusted earnings per share $4.80 to $5.00, compared with Oppenheimer estimate of $4.90, according to the note.</p><p>Oppenheimer said it remains constructive long-term given the company's ecosystem and multiple growth levers, although China, tariffs, and other macro pressures remain as overhangs.</p><p>Oppenheimer maintained its outperform rating with a price target of $85 on GE HealthCare.</p><p>Price: 69.04, Change: -2.86, Percent Change: -3.98</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GE","symbol_name":"GE航空航天","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2655807289","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655807289","pubTimestamp":1785433878,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GE HealthCare Technologies' (GEHC) continued underperformance in the Patient Care Solutions business is \"disappointing,\" with the segment experiencing fulfillment challenges in Q2, Oppenheimer said in","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"GE":"GE航空航天","OPY":"奥本海默控股"},"translate_title":"奥本海默表示，GE HealthCare 在患者护理解决方案业务方面持续表现不佳“令人失望”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPY":1.5,"GE":1.5},"content_text":"GE HealthCare Technologies' (GEHC) continued underperformance in the Patient Care Solutions business is \"disappointing,\" with the segment experiencing fulfillment challenges in Q2, Oppenheimer said in a Thursday note.The company is exploring a strategic review for PCS, which includes either continued ownership, sale, or other value enhancing transactions, Oppenheimer said, adding that the timeline of the review remains unclear, with GE HealthCare looking to stabilize the business first.Additionally, the company reiterated organic revenue growth at 3% to 4%, as well as adjusted earnings per share $4.80 to $5.00, compared with Oppenheimer estimate of $4.90, according to the note.Oppenheimer said it remains constructive long-term given the company's ecosystem and multiple growth levers, although China, tariffs, and other macro pressures remain as overhangs.Oppenheimer maintained its outperform rating with a price target of $85 on GE HealthCare.Price: 69.04, Change: -2.86, Percent Change: -3.98","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}